全文获取类型
收费全文 | 155553篇 |
免费 | 31084篇 |
国内免费 | 2438篇 |
专业分类
耳鼻咽喉 | 5315篇 |
儿科学 | 5610篇 |
妇产科学 | 2669篇 |
基础医学 | 3339篇 |
口腔科学 | 1709篇 |
临床医学 | 26971篇 |
内科学 | 48394篇 |
皮肤病学 | 7498篇 |
神经病学 | 15017篇 |
特种医学 | 6541篇 |
外科学 | 42016篇 |
综合类 | 359篇 |
现状与发展 | 72篇 |
一般理论 | 1篇 |
预防医学 | 7174篇 |
眼科学 | 3464篇 |
药学 | 1081篇 |
中国医学 | 19篇 |
肿瘤学 | 11826篇 |
出版年
2024年 | 687篇 |
2023年 | 4812篇 |
2022年 | 1241篇 |
2021年 | 3185篇 |
2020年 | 6079篇 |
2019年 | 2245篇 |
2018年 | 7481篇 |
2017年 | 7399篇 |
2016年 | 8563篇 |
2015年 | 8545篇 |
2014年 | 15638篇 |
2013年 | 15870篇 |
2012年 | 5835篇 |
2011年 | 5814篇 |
2010年 | 10530篇 |
2009年 | 14410篇 |
2008年 | 6118篇 |
2007年 | 4374篇 |
2006年 | 6844篇 |
2005年 | 4097篇 |
2004年 | 3327篇 |
2003年 | 2215篇 |
2002年 | 2246篇 |
2001年 | 3851篇 |
2000年 | 3042篇 |
1999年 | 3245篇 |
1998年 | 3640篇 |
1997年 | 3458篇 |
1996年 | 3363篇 |
1995年 | 3207篇 |
1994年 | 1938篇 |
1993年 | 1562篇 |
1992年 | 1387篇 |
1991年 | 1409篇 |
1990年 | 1061篇 |
1989年 | 1181篇 |
1988年 | 1025篇 |
1987年 | 859篇 |
1986年 | 898篇 |
1985年 | 734篇 |
1984年 | 556篇 |
1983年 | 527篇 |
1982年 | 520篇 |
1981年 | 404篇 |
1980年 | 364篇 |
1979年 | 319篇 |
1978年 | 336篇 |
1977年 | 400篇 |
1975年 | 279篇 |
1972年 | 310篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
72.
73.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
74.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
75.
76.
77.
78.
Juliette A. Loncaster MD FRCR Ernest Allan 《Photodiagnosis and Photodynamic Therapy》2006,3(2):134-137
Gorlin syndrome (naevoid basal cell carcinoma syndrome) is a genetically linked disorder characterized by the development of multiple basal cell carcinomas (BCCs) throughout life. Cumulative surgery, cryotherapy and other conventional interventions can result in significant disfigurement by middle age. Radiotherapy is contra-indicated because the mutated gene underlying the syndrome, ‘PTCH’, increases sensitivity to ionising radiation, so there is significant likelihood of inducing further tumours in and around the irradiated area. Photodynamic therapy offers a non-invasive treatment option for patients with this condition, with the added advantage of causing minimal scarring. 相似文献
79.
Özlem Keskin Ayfer Tuncer Gonul Adalioglu Bulent E. Sekerel Cansn Saçkesen Omer Kalayc 《Pediatric allergy and immunology》2006,17(6):396-407
Allergoid immunotherapy is a new form of allergen immunotherapy allowing safe administration of high allergen doses. There is limited information on the effects of allergoid immunotherapy in children with allergic rhinitis. To investigate the immunological and clinical effects of allergoid immunotherapy in children with allergic rhinitis due to grass pollen allergy. Children with allergic rhinitis were assigned to allergoid immunotherapy (n = 27) or control (n = 26, no immunotherapy) groups. Children in the immunotherapy group received seven injections of grass pollen allergoid immunotherapy before grass pollen season and continued to receive maintenance immunotherapy for 27 months. All patients were offered a pharmacotherapy regimen to be used on demand during the pollen seasons. Clinical and laboratory parameters were compared between the immunotherapy and control groups. The rhinoconjunctivitis symptom-medication score and asthma symptom score were lower in the immunotherapy group after 1 yr of maintenance immunotherapy (p < 0.01 for both). Skin test reactivity and nasal reactivity as determined by nasal provocation testing for grass pollen were significantly decreased after 1 yr of immunotherapy (p < 0.001 for both). The seasonal increase in bronchial reactivity and nasal lavage eosinophil cationic protein levels were prevented after the first year of immunotherapy (p < 0.05 for both). The seasonal increase in immunoglobulin (Ig)E decreased (p < 0.05) and grass-specific IgG, IgG(1) and IgG(4) increased significantly already at the end of the seven-injection build-up therapy (p < 0.001, for all). Interleukin (IL)-4 levels in the culture supernatants showed a steady decline from baseline at first and second year of immunotherapy (p < 0.001) but remained unchanged in the control group. Allergoid immunotherapy is an effective method in the treatment of grass pollen-induced allergic rhinitis in children and prevents the seasonal increase in bronchial hyper-reactivity. Changes in specific IgE and IgG levels and decreased IL-4 production in peripheral blood mononuclear cell culture supernatants may account for the observed clinical effects. 相似文献
80.